Home

Richard Kuntz

CIK 1341125 · SVP & Chief Medical & Science · last filed 2026-08-03

Richard Kuntz is a SVP & Chief Medical & Science who has filed 88 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for INVE, was dated Aug 3, 2026. Across all open-market trades the lifetime net is −$29.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.1M across reported positions. 33 SEC filings were submitted jointly with Medtronic plc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$7.14M

Companies

6

Total Filings

88

Lifetime Open-Market Net

-$29.40M

Filer Profile

Reported Address
C/O DIAMEDICA THERAPEUTICS INC.
301 CARLSON PARKWAY, SUITE 210
MINNEAPOLIS, MN 55305
Related Filers
Medtronic plc — 33 joint filings, latest 2021-11-09
MEDTRONIC INC — 27 joint filings, latest 2015-01-28
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INVE Director 65,712 $2.58 $169.5K $0 5 2026-08-03
DMAC Director 24,210 $6.47 $156.6K $0 6 2026-06-03
ZimVie Inc. (ZIMV) Delisted Director — $18.99 — $0 17 2025-10-20
Rockley Photonics Holdings Ltd (RKLY.WS) Delisted Director — $0.04 — $0 2 2022-08-31
MDT SVP & Chief Medical & Science 74,945 $90.96 $6.82M -$36.40M 53 2021-11-09
TENGION INC (TNGN) Delisted Director 0 — — $7.00M 5 2012-05-22

Recent Filings

88 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-03 INVE Grant (A) +17,544 $0 EDGAR
2026-06-03 DMAC Grant (A) — $0 EDGAR
2025-10-20 ZimVie Inc. (ZIMV) Delisted Disp (D) — $0 EDGAR
2025-10-02 ZimVie Inc. (ZIMV) Delisted Grant (A) — $0 EDGAR
2025-07-31 INVE Grant (A) +21,148 $0 EDGAR
2025-07-02 ZimVie Inc. (ZIMV) Delisted Grant (A) — $0 EDGAR
2025-06-03 DMAC Grant (A) — $0 EDGAR
2025-05-09 ZimVie Inc. (ZIMV) Delisted Grant (A) — $0 EDGAR
2025-04-02 ZimVie Inc. (ZIMV) Delisted Grant (A) — $0 EDGAR
2025-01-03 DMAC Grant (A) +9,925 $53.0K EDGAR
Showing 1–10 of 88
Page 1 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.